Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Global X Lithium & Battery Tech ETF (LIT) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance

Global X Lithium & Battery Tech ETFTrade
Nuvation Bio Inc. Class A Common StockTrade

Price performance (Past 24H)

Key statistics

Global X Lithium & Battery Tech ETF vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Global X Lithium & Battery Tech ETF trades at $69.72 (market cap $1.45B), while Nuvation Bio Inc. Class A Common Stock trades at $4.98 (market cap $1.74B). The key difference: Nuvation Bio Inc. Class A Common Stock is the larger of the two by market cap, and Global X Lithium & Battery Tech ETF is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X Lithium & Battery Tech ETF for 56 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.

LITNUVB
Market Cap
$1.45B$1.74B
Volume
89,3929,289,619
Sector
Commodities - Metals/AgricultureHealth
52-Week High
$91.62$9.54
52-Week Low
$53.92$3.41
Typical Hold Time
56 Days1 Days
Enterprise Value
—$1.33B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Global X Lithium & Battery Tech ETF

LIT (Global X Lithium & Battery Tech ETF) trades at $69.51, down 2.2% with mixed technical signals showing a bullish overall trend but bearish moving averages and oscillators. Recent news highlights significant short interest decline (53.1% drop in September 2026) and positive catalysts from EV adoption trends. The ETF's performance reflects ongoing volatility in lithium markets amid shifting commodity prices and global electrification policies.

Outlook remains driven by long-term EV growth, though near-term risks include lithium price volatility and geopolitical tensions. Investment opportunity lies in exposure to battery technology leaders, balanced by sector-specific supply chain and regulatory uncertainties that could impact shareholder returns.

Nuvation Bio Inc. Class A Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Global X Lithium & Battery Tech ETF

LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.

Read more on LIT →

About Nuvation Bio Inc. Class A Common Stock

Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.

Read more on NUVB →